LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, has provided an update following its attendance at HLTH Europe 2026, a leading healthcare innovation conference. The company reported that the event offered valuable opportunities to engage with healthcare innovators, technology companies, providers, insurers, and digital health organizations from Europe, Latin America, and other international markets.
Management noted that HLTH Europe increased awareness of the company's developing healthcare technology platform among a broad range of industry participants. The company believes that engagement with global healthcare stakeholders is an important component of its long-term strategy as it advances the development of its integrated healthcare ecosystem throughout Latin America.
The conference reinforced management's belief that healthcare systems increasingly require integrated digital solutions capable of improving patient accessibility, care coordination, financial accessibility, and operational efficiency. Management observed growing interest across the healthcare sector in artificial intelligence applications, telehealth infrastructure, healthcare payments, insurance accessibility initiatives, and technology-enabled patient engagement solutions.
The company stated that many of the themes discussed align closely with its ongoing efforts to develop an integrated healthcare ecosystem combining telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and artificial intelligence-driven solutions.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “HLTH Europe provided an outstanding opportunity to engage with healthcare and technology professionals from across Europe, Latin America, and other international markets. One of the most encouraging takeaways from the conference was the growing industry focus on integrated healthcare platforms that combine accessibility, coordination, financial solutions, and technology-enabled patient engagement. We believe many of these trends align closely with the direction of our broader healthcare ecosystem strategy and reinforce our long-term vision for LataMed AI. The conference also provided valuable visibility for our platform initiatives and an opportunity to establish new industry relationships that may support our future growth objectives.”
The company is currently reviewing and evaluating various follow-up opportunities resulting from discussions held during the conference and intends to provide additional updates regarding any material developments as appropriate. Photographs and highlights from the company's attendance at HLTH Europe 2026 are available through LataMed AI's official Instagram page.
For additional information, please visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
